Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 15Incyte Corporation

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

PEMIGATINIB

Brand Name : PEMAZYRE

Dosage Form : TABLET;ORAL

Dosage Strength : 4.5MG

Packaging :

Approval Date : 2020-04-17

Application Number : 213736

Regulatory Info : RX

Registration Country : USA

blank

02

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

PEMIGATINIB

Brand Name : PEMAZYRE

Dosage Form : TABLET;ORAL

Dosage Strength : 9MG

Packaging :

Approval Date : 2020-04-17

Application Number : 213736

Regulatory Info : RX

Registration Country : USA

blank

03

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

PEMIGATINIB

Brand Name : PEMAZYRE

Dosage Form : TABLET;ORAL

Dosage Strength : 13.5MG

Packaging :

Approval Date : 2020-04-17

Application Number : 213736

Regulatory Info : RX

Registration Country : USA

blank

04

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Pemigatinib

Brand Name : Pemazyre

Dosage Form : Tablet

Dosage Strength : 13.5mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20191122000062

Regulatory Info : Approved

Registration Country : Sweden

blank

05

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Pemigatinib

Brand Name : Pemazyre

Dosage Form : Tablet

Dosage Strength : 4.5mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20191122000048

Regulatory Info : Approved

Registration Country : Sweden

blank

06

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Pemigatinib

Brand Name : Pemazyre

Dosage Form : Tablet

Dosage Strength :

Packaging :

Approval Date : 26/03/2021

Application Number : 20191122000055

Regulatory Info : Approved

Registration Country : Sweden

blank

07

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Pemigatinib

Brand Name : Pemazyre

Dosage Form : Tablet

Dosage Strength : 4.5mg

Packaging :

Approval Date : 13/07/2021

Application Number : 68143

Regulatory Info : Limited-Term

Registration Country : Switzerland

blank

08

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Pemigatinib

Brand Name : Pemazyre

Dosage Form : Tablet

Dosage Strength : 9mg

Packaging :

Approval Date : 13/07/2021

Application Number : 68143

Regulatory Info : Limited-Term

Registration Country : Switzerland

blank

09

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Pemigatinib

Brand Name : Pemazyre

Dosage Form : Tablet

Dosage Strength : 13.5mg

Packaging :

Approval Date : 13/07/2021

Application Number : 68143

Regulatory Info : Limited-Term

Registration Country : Switzerland

blank

10

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Pemigatinib

Brand Name : Pemazyre

Dosage Form : Tablet

Dosage Strength : 13.5MG

Packaging :

Approval Date : 2021-05-10

Application Number : 1211535005

Regulatory Info : Authorized

Registration Country : Spain

blank

11

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Pemigatinib

Brand Name : Pemazyre

Dosage Form : Tablet

Dosage Strength : 4.5MG

Packaging :

Approval Date : 2021-05-07

Application Number : 1211535001

Regulatory Info : Authorized

Registration Country : Spain

blank

12

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Pemigatinib

Brand Name : Pemazyre

Dosage Form : Tablet

Dosage Strength : 9MG

Packaging :

Approval Date : 2021-05-07

Application Number : 1211535003

Regulatory Info : Authorized

Registration Country : Spain

blank

13

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

PEMIGATINIB

Brand Name : PEMAZYRE

Dosage Form : TABLET

Dosage Strength : 4.5MG

Packaging :

Approval Date :

Application Number : 2519933

Regulatory Info : Prescription

Registration Country : Canada

blank

14

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

PEMIGATINIB

Brand Name : PEMAZYRE

Dosage Form : TABLET

Dosage Strength : 9MG

Packaging :

Approval Date :

Application Number : 2519941

Regulatory Info : Prescription

Registration Country : Canada

blank

15

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

PEMIGATINIB

Brand Name : PEMAZYRE

Dosage Form : TABLET

Dosage Strength : 13.5MG

Packaging :

Approval Date :

Application Number : 2519968

Regulatory Info : Prescription

Registration Country : Canada

blank